Porth's Essentials of Pathophysiology, 4e

915

Disorders of Neuromuscular Function

C h a p t e r 3 6

Harrison’s Neurology in Clinical Medicine . 2nd ed. New York: McGraw-Hill; 2010:435–450. 47. Courtney AM, Treadaway K, Remington G, et al. Multiple sclerosis. Med Clin North Am. 2009;93:451–476. 48. Peterson JW, Trapp BD. Neuropathology of multiple sclerosis. Neurol Clin. 2005;23:107–129. 49. Nylander A, Hafler DA. Multiple sclerosis. J Clin Invest. 2012;122(4):1180–1186. 50. Frohman EM, Racke MK, Raine CS. Mulltiple sclerosis—the plaque and its pathogenesis. N Engl J Med. 2006;345(9):942–955. 51. Lubin DD. Clinical features and diagnosis of multiple sclerosis. Neurol Clin. 2005;23:1–15. 52. Kita M. FDA-approved preventative therapies for MS; first-line agents. Neurol Clin. 2011;29:401–409. 53. NSCISC National Spinal Cord Injury Statistical Center. Spinal cord injury: Facts and figures at a glance . Birmingham, AL: University of Alabama; 2013. [Online] Available at: https:// www.nscisc.uab.edu/PublicDocuments/fact_figures_docs/ Facts%202013.pdf. Accessed September 19, 2013. 54. McDonald JW. Spinal cord injury. Lancet. 2002;359:417–425. 55. Wilson JR, Fehlings MG. Emerging approaches to the surgical management of acute traumatic spinal cord injury. Neurotherapeutics. 2011;8:187–194. 56. Gupta R, Bathen ME, Smith JS, et al. Advances in the management of spinal cord injury. J Am Acad Orthop Surg. 2010;18(4):210–222. 57. Branco F, Cardenas DD, Svircev JN. Spinal cord injury: a comprehensive review. Phys Med Rehabil Clin N Am. 2007;18:651–679. 58. Dietrich WD. Therapeutic hypothermia in spinal cord injury. Crit Care Med. 2009;37(7):S238–S243. 59. Kirshblum SC, Burns SP, Biering-Sorensen F. International standards for neurological classification of spinal cord injury (revised 2011). J Spinal Cord Med. 2011;34(6):535–547. 60. Lo V, Esquenazi A, Han MK, et al. Critical care management of patients with acute spinal cord injury. J Neurosurg Sci. 2013;57(4):281–292. 61. Zimmer MB, Nantwi K, Goshgarian HG. Effect of spinal cord injury on the respiratory system: basic research and current clinical treatment options. J Spinal Cord Med. 2007;30:319–330.

62. Garstang SV, Miller-Smith SA. Autonomic nervous system dysfunction after spinal cord injury. Phys Med Rehabil Clin N Am. 2007:18, 275–296. 63. Krassioukov A, Warburton DER, Tessel R, et al. A systematic review of the management of autonomic dysreflexia following spinal cord injury. Arch Phys Med Rehabil. 2009;90(4):682–695. 64. Cruz CD, Cruz F. Spinal cord injury and bladder dysfunction: new ideas about an old problem. Scientific World Journal. 2011;11:214–234. 65. Riccardi R, Szabo CM, Poullos AY. Sexuality and spinal cord injury. Nurs Clin North Am. 2007;42:677–684. 66. Tessell RW, Hsieh TJ, Aubut JAL, et al. Venous thromboembolism following spinal cord injury. Arch Phys Med Rehabil. 2009;90(2):232–245. 67. Tohda C, Kuboyama T. Current and future therapeutic strategies for functional repair of spinal cord injury. Pharmacol Ther. ;2011;132(1):57–71. 68. Mothe A, Tator CH. Advances in stem cell therapy for spinal cord injury. J Clin Invest. 2012;122(11):3823–3834. 69. Wilson J, Forgione N, Fehlings MG. Emerging therapies for acute traumatic spinal cord injury. CMAJ. 2013;185(6):485–492. 70. Varma AK, Das A, Wallace G IV, et al. Spinal cord injury: a review of current therapy, future treatments, and basic science frontiers. Neurochem Res. 2013;38:895–905. 71. Bracken MB. Steroids for acute spinal cord injury. Cochrane Database Syst Rev 2012;1:CD001046.

Porth Essentials Resources Explore these additional resources to enhance learning for this chapter: •  NCLEX-Style Questions and Other Resources

on

, http://thePoint.lww.com/PorthEssentials4e

• Study Guide for Essentials of Pathophysiology • Adaptive Learning | Powered by PrepU, http://thepoint.lww.com/ prepu